Drastic healing process after pembrolizumab monotherapy in a case of advanced squamous cell carcinoma with severe bronchial stenosis observed over a two‐year period using continuous bronchoscopy: A case report

Programmed cell death‐1 immune checkpoint inhibitor (ICI) antibody has proven to be effective in advanced non‐small cell lung cancer (NSCLC) patients positive for programmed cell death‐1 ligand‐1. However, there are currently no reports which evaluate drug efficacy by continuous bronchoscopic observ...

Full description

Bibliographic Details
Main Authors: Kei Morikawa, Hirotaka Kida, Hiroshi Handa, Takeo Inoue, Teruomi Miyazawa, Masamichi Mineshita
Format: Article
Language:English
Published: Wiley 2020-05-01
Series:Thoracic Cancer
Subjects:
Online Access:https://doi.org/10.1111/1759-7714.13390